Identification of multi-drug resistant Pseudomonas aeruginosa clinical isolates that are highly disruptive to the intestinal epithelial barrier

被引:52
|
作者
Zaborina O. [1 ]
Kohler J.E. [1 ]
Wang Y. [2 ]
Bethel C. [3 ]
Shevchenko O. [1 ]
Wu L. [1 ]
Turner J.R. [2 ]
Alverdy J.C. [1 ]
机构
[1] Department of Surgery, University of Chicago, Chicago, IL
[2] Department of Pathology, University of Chicago, Chicago, IL
[3] Clinical Microbiology Laboratories, University of Chicago, Chicago, IL
关键词
Clinical Isolate; Intestinal Epithelium; Transepithelial Resistance; Intestinal Epithelial Barrier; exoS Gene;
D O I
10.1186/1476-0711-5-14
中图分类号
学科分类号
摘要
Background: Multi-drug resistant Pseudomonas aeruginoso nosocomial infections are increasingly recognized worldwide. In this study, we focused on the virulence of multi-drug resistant clinical strains P. aeruginosa against the intestinal epithelial barrier, since P. aeruginosa can cause lethal sepsis from within the intestinal tract of critically ill and immuno-compromised patients via mechanisms involving disruption of epithelial barrier function. Methods: We screened consecutively isolated multi-drug resistant P. aeruginosa clinical strains for their ability to disrupt the integrity of human cultured intestinal epithelial cells (Caco-2) and correlated these finding to related virulence phenotypes such as adhesiveness, motility, biofilm formation, and cytotoxicity. Results: Results demonstrated that the majority of the multi-drug resistant P. aeruginosa clinical strains were attenuated in their ability to disrupt the barrier function of cultured intestinal epithelial cells. Three distinct genotypes were found that displayed an extreme epithelial barrier-disrupting phenotype. These strains were characterized and found to harbor the exoU gene and to display high swimming motility and adhesiveness. Conclusion: These data suggest that detailed phenotypic analysis of the behavior of multi-drug resistant P. aeruginosa against the intestinal epithelium has the potential to identify strains most likely to place patients at risk for lethal gut-derived sepsis. Surveillance of colonizing strains of P. aeruginosa in critically ill patients beyond antibiotic sensitivity is warranted. © 2006 Zaborina et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [1] Multi-drug and extreme-drug resistance in clinical isolates of Pseudomonas aeruginosa
    Awanye, Amaka
    Ibezim, Chidozie
    Stanley, Catherine
    Okonko, Iheanyi
    Egbe, Nkechi
    PHARMACY EDUCATION, 2023, 23 (03): : 55 - 59
  • [2] Frequency and Antibiogram of Multi-drug Resistant Pseudomonas aeruginosa
    Gill, Maria Mushtaq
    Usman, Javaid
    Kaleem, Fatima
    Hassan, Afreenish
    Khalid, All
    Anjum, Rabia
    Fahim, Qanita
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2011, 21 (09): : 531 - 534
  • [3] Effects of Glycyrrhizin on Multi-Drug Resistant Pseudomonas aeruginosa
    Carruthers, Nicholas J.
    McClellan, Sharon A.
    Somayajulu, Mallika
    Pitchaikannu, Ahalya
    Bessert, Denise
    Peng, Xudong
    Huitsing, Kylie
    Stemmer, Paul M.
    Hazlett, Linda D.
    PATHOGENS, 2020, 9 (09): : 1 - 14
  • [4] Clinical Use of Inhaled Bacteriophages to Treat Multi-Drug Resistant Pseudomonas Aeruginosa
    Koff, J. L.
    Chan, B. K.
    Stanley, G. L.
    Geer, J. H.
    Grun, C.
    Kazmerciak, B.
    Turner, P. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] Molecular Epidemiology of Multi-Drug Resistant Pseudomonas aeruginosa Isolates from Hospitalized Patients in Greece
    Pappa, Olga
    Kefala, Anastasia Maria
    Tryfinopoulou, Kyriaki
    Dimitriou, Marios
    Kostoulas, Kostas
    Dioli, Chrysa
    Moraitou, Eleni
    Panopoulou, Maria
    Vogiatzakis, Evaggelos
    Mavridou, Athena
    Galanis, Alex
    Beloukas, Apostolos
    MICROORGANISMS, 2020, 8 (11) : 1 - 16
  • [6] Yakult: a role in combating multi-drug resistant Pseudomonas aeruginosa?
    Thomson, C. H.
    Hassan, I.
    Dunn, K.
    JOURNAL OF WOUND CARE, 2012, 21 (11) : 566 - 569
  • [7] Effects of Glycyrrhizin on Multi-Drug Resistant Pseudomonas aeruginosa.
    Hazlett, Linda D.
    McClellan, Sharon
    Somayajulu, Mallika
    Pitchaikannu, Ahalya
    Carruthers, Nicholas
    Stemmer, Paul
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [8] INVESTIGATION OF AN EPIDEMIC OF MULTI-DRUG RESISTANT PSEUDOMONAS-AERUGINOSA
    MURRAY, SA
    SNYDMAN, DR
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1982, 3 (06): : 456 - 460
  • [10] Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections
    Diaz Santos, E.
    Mora Jimenez, C.
    del Rio-Carbajo, L.
    Vidal-Cortes, P.
    MEDICINA INTENSIVA, 2022, 46 (09) : 508 - 520